# Corporate director referral questions: ten cards | SourceX

Canonical: https://refer.sourcex.si/guides/a-corporate-director-s-data-opportunity-question-set
Last updated: 2026-11-05

A corporate director can raise the company's own records as a topic in the normal course of board work: as a strategy question about what the company knows that others cannot easily rebuild, a risk question about who may use its data, and a contract question about what customer agreements allow. Ask those questions without naming a vendor, and keep the answers inside the boardroom. SourceX enters the conversation only if the CEO wants it there, and only after the director has disclosed any personal interest. The CEO decides.

This page is for company directors, whether independent or fund partners in outside seats, and for the venture relationship partners who maintain a fund's network of directors. It gives no legal advice: a director's duties come from the company's governing law and documents, and its counsel and conflict policy govern what follows.

## Duties come before questions

A board seat brings obligations before it brings opportunities. The 2023 G20/OECD Principles of Corporate Governance list among the board's key functions "Reviewing and guiding corporate strategy, major plans of action, annual budgets and business plans" (search excerpt), and set out board members' duty of care and duty of loyalty, with acting on a fully informed basis part of the duty of care (our paraphrase). The Principles also note that how these functions are carried out differs with company size, industry and board structure.

Two practical conclusions follow for this topic, and neither is legal advice.

1. **Asking about the company's data assets is ordinary board work.** What the company knows, what it may do with that knowledge and what its contracts allow are strategy and oversight questions. A director does not need a vendor in mind to ask them.
2. **Naming a vendor you could benefit from is not ordinary board work.** The moment a question carries a personal interest, it raises a conflict question to be disclosed and handled under the company's own process. The guide to a [sponsor-appointed director's duties](/guides/fiduciary-duties-private-equity-board-designee) treats board information as the company's and describes written disclosure and recusal where counsel advises it.

Under the referral program, the CEO authorizes a licensing discussion and signs for the company. SourceX's screening page makes the same point about investor directors: a board seat lets a fund speak in the boardroom, but it does not let the fund start a licensing discussion.

## Three settings, three kinds of question

| Setting | Questions that fit | Questions that do not |
|---|---|---|
| Strategy session or offsite | What the company knows from years of operation, and whether that knowledge has uses beyond the business | Any question that names a program or vendor |
| Risk, audit or contract review | What customer and supplier agreements allow, whether anything has been licensed before, who answers approaches | Requests to see contracts or records outside the committee's normal remit |
| One-to-one with the CEO | How the CEO wants directors to handle anything they hear about data licensing | An introduction offer before your interest is disclosed |

## The board-context question cards

Ten cards in four suits. Each is a question a director can ask in the setting shown, without naming a vendor and without asking to see a record.

| # | Suit | The question | Setting | A useful answer sounds like | Never ask for |
|---|---|---|---|---|---|
| 1 | Strategy | What do we know from years of operating that a newcomer could not easily rebuild? | Strategy session | Fifteen years of service jobs, with what went wrong on each | Examples drawn from customer files |
| 2 | Strategy | Which systems hold that history, and since when? | Strategy session | Work orders since 2010 in one system, run by operations | Exports, samples or screenshots |
| 3 | Strategy | Has management considered whether any of it has value outside the business, for example for AI training or evaluation? | Strategy session | Not yet; worth a look next year | A forecast of what it might earn |
| 4 | Rights and risk | Do our customer and supplier contracts limit reuse of records we created while serving them? | Contract or risk review | Most contracts are silent; two large ones restrict it | The contracts themselves, outside the committee's remit |
| 5 | Rights and risk | Have we ever licensed data for AI training, or been approached to? | Risk review | Never | Details of any approach that management treats as confidential |
| 6 | Rights and risk | If someone asked to license or buy our data, who would answer, and how would the board hear? | Risk review | The CEO, with counsel; the board hears before anything is signed | A role for any director in the answer |
| 7 | Process | Is now a sensible time to look at this at all? | Chair or CEO, privately | After the financing closes | Pressure to look during a sale or crisis |
| 8 | Process | Would you like directors to pass on programs they hear about, or would you rather look yourself? | CEO one-to-one | Send me anything you think is credible | Permission to approach staff |
| 9 | Interest | Do I hold any interest in this field that I must disclose before this goes further? | The director, privately, then the board as policy requires | Yes: I am a registered referral partner | Silence |
| 10 | Interest | Should I step back from this discussion? | Chair or counsel | Disclose in writing and step out of any decision | A director's own view as the deciding one |

Card 5 has a practical edge. SourceX's process page lists, among what a supplier confirms, that its data has not been licensed for AI training before. An earlier license changes what is possible later, which is a reason to know the answer whatever vendor the company might ever consider.

Card 9 is the hinge. A director who is a SourceX referral partner, or works for a firm that is, says so in writing before card 3 goes any further, and the company's conflict process takes over. Whether a director can keep a reward at all is discussed in [whether a board member can take a referral reward](/questions/board-member-conflict-of-interest-referral-fee), which also covers making the introduction without one.

**Methods note.** The cards apply the 2023 G20/OECD Principles' description of board functions and duties (a search excerpt), SourceX's screening and process pages and the program terms (Version 2026-10-22.2, since replaced by version 2026-11-04), all checked on 2026-10-27. They are this page's design, not a governance standard, and they measure nothing. No figures have been published on how often board questions of this kind lead to a licensing conversation.

## If the CEO asks about SourceX

The CEO may come back, sometimes months later, asking whether you know of programs in this area. Then:

1. **Disclose first, in writing.** Your partner status, who pays a reward, the formula and the cap, before you describe the program.
2. **Follow the company's process.** Recusal, approval by directors without an interest, or declining the reward, as the company's policy and counsel direct.
3. **Offer two routes.** The CEO can apply directly without you, or you can make the introduction with the CEO's written yes. Either way the company deals with SourceX itself.
4. **Carry nothing from the boardroom.** Board materials, figures and plans stay with the company. If you introduce, you pass the company's name and the CEO's agreement.
5. **Say what does not change.** What the company would be paid is the same with or without a partner, because section 4 of the terms says "The referral reward is paid separately by SourceX and is never deducted from the supplier's agreed compensation."

If you go ahead as the introducer, sign the SourceX Channel Partner Agreement before submitting. SourceX credits the first valid introduction of a company that is new to it, decided from dated records, once the company files a verified application inside the 90-day attribution window. Earlier contact between the company and SourceX makes it a duplicate.

## Who can reach the company's CEO

- **The company where you sit.** You can reach the CEO directly. That proximity is exactly why disclosure comes first.
- **Other companies in your network.** Each CEO decides for their own company, and what you learn in one boardroom stays there. Companies that compete with each other need the extra care set out in [board networks that cross competing companies](/guides/when-a-board-network-crosses-competing-companies).
- **An advisory seat instead of a board seat.** Different obligations apply; use [the board advisor checklist](/guides/when-a-board-advisor-can-open-the-right-company-door).
- **An acquired company.** After closing, the acquirer's CEO decides, and the group shares one reward cap.

Fit is still decided on the company's own facts: full-time headcount that reached 50 at its peak, contractors excluded; years of records it created; rights to license them without breaching client confidentiality or third-party contracts. Companies in the U.S., Canada and the EU qualify, as do companies in the UK, Australia, New Zealand, India, Singapore, South Africa, Latin America, the UAE and Saudi Arabia when at least 70% of the data is in English.

## One director, one year (Illustrative)

Illustrative. A generic company and director; invented facts, no outcome implied.

An independent director of a 420-person specialty insurer raises cards 1 and 4 at the annual strategy offsite. Management says claim files go back to 2009 and that a few broker agreements may restrict reuse. Nothing more happens for two quarters. Then the CEO asks her, one to one, whether she knows any credible licensing programs. She replies in writing that she is a registered SourceX referral partner, describes the reward, offers to step out of any board discussion and suggests the company apply directly so that no reward is involved. The chair records the disclosure. The CEO applies directly.

## Investment, endorsement and pay stay apart

- **No capital conversation.** A director who is also a fund partner never pairs these questions with an investment, a financing or a board-seat discussion.
- **No endorsement.** Raising the topic does not suggest the company qualifies, that SourceX endorses the director, or that anyone gets preferential access to the company's data.
- **No collection.** Directors never gather records, contracts or system details for SourceX.
- **Relationship partners share the cards, not the seats.** A fund's relationship team can give directors in its network this question set. It never asks a director to report board answers back to the fund.

## Risks and limits

- **Duties differ by company.** Entity type, governing law and documents change what a director may and must do; the OECD Principles themselves say practice varies. Ask the company's counsel.
- **Conflicts are real even at no cost to the company.** A reward paid by SourceX still ties a director's income to a company decision.
- **Confidentiality outlasts the meeting.** Treat board answers as confidential even after you leave the seat; the company's own documents say how long the duty runs.
- **Fit and demand are decided in review.** A good answer to card 1 says nothing about whether any program wants the records.
- **Our thesis is untested.** We expect vendor-neutral board questions, asked a year before any program comes up, to produce better-informed CEO decisions than an introduction offered cold. Test it: count cards asked, CEOs who later asked about programs and disclosures made before any introduction.

Further playbooks for people who hold seats and relationships sit in the [guides library](/guides).

## Next step

> **Refer a company. No cap on rewards.** Default reward on a company's first qualifying transaction: the greater of $50,000 plus 5% and 15% of Actual Supplier Payout, with no cap; further qualifying transactions first agreed within 12 months of the first Closing pay 15%. Eligibility and payment conditions apply, including the USD 100,000 Minimum Transaction, and a signed Schedule A or addendum can differ. A lead, meeting or signature alone does not trigger payment.

If, after your written disclosure, the CEO asks you to make the introduction, [register for a partner account](/register), weigh the company against the [published fit criteria](/who-qualifies) and go through the [program terms](/terms) with the company's conflict process in view.

Board questions about the company's records are governance work, and referring a company is a separate choice; evaluating SourceX as an investment is a third, handled by request on the [SourceX investor page](https://sourcex.si/investors).

This article is for information only and is not an offer to sell or a solicitation of an offer to buy securities. Any offering by SourceX is made only to verified accredited investors through its offering documents.

## Sources

- https://www.oecd.org/en/publications/2023/09/g20-oecd-principles-of-corporate-governance-2023_60836fcb/full-report/component-8.html
- https://sourcex.si/how-it-works
- https://refer.sourcex.si/who-qualifies
- https://refer.sourcex.si/terms
- https://sourcex.si/investors
